Pharmacological enhancement of vagal tone using galantamine, an inhibitor of the ACh degradation enzyme (acetylcholine esterase, AChE), reduces hepatic inflammation, steatosis, and systemic insulin resistance 186,187. This evidence concerns the gene ACHE and Insulin resistance.